Matthew Morgan
Publications by Year
Research Areas
Ion Channels and Receptors, Phytochemicals and Antioxidant Activities, Biochemical Analysis and Sensing Techniques, Healthcare Policy and Management, Primary Care and Health Outcomes
Most-Cited Works
- → An Inconvenient Truth: A Sustainable Healthcare System Requires Chronic Disease Prevention and Management Transformation(2007)67 cited
- → Stereospecific High-affinity TRPV1 Antagonists: Chiral N-(2-Benzyl-3-pivaloyloxypropyl) 2-[4-(methylsulfonylamino)phenyl]propionamide Analogues(2007)30 cited
- → Analysis of structure–activity relationships for the ‘A-region’ of N-(4-t-butylbenzyl)-N′-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonists(2005)24 cited
- → Analysis of structure–activity relationships for the ‘B-region’ of N-(4-t-butylbenzyl)-N′-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists(2005)13 cited
- → N-4-t-Butylbenzyl 2-(4-methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure–activity relationships in the A-region(2011)12 cited
- → Non-vanillyl resiniferatoxin analogues as potent and metabolically stable transient receptor potential vanilloid 1 agonists(2008)10 cited
- → The SAR analysis of TRPV1 agonists with the α-methylated B-region(2012)7 cited
- → 2-(4-Methylsulfonylaminophenyl) propanamide TRPV1 antagonists: Structure–activity relationships in the B and C-regions(2011)4 cited
- → The Authors Respond(2007)3 cited
- → Boron-Nitrogen Doped Dihydroindeno[1,2-b]fluorene Derivatives as Acceptors in Organic Solar Cells(2019)